Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
作者信息
Tazaki Y, Omae T, Kuromaru S, Ohtomo E, Hasegawa K, Mori A, Kurihara M, Kutsusawa N, Okada T
出版信息
J Int Med Res. 1980;8(2):118-26. doi: 10.1177/030006058000800203.
PMID:6989681
Abstract
The results of a series of multicentre, controlled, double-blind trials of the clinical efficacy of Encephabol compared with placebo in patients with a variety of cerebrovascular disorders are reported.
摘要
相似文献
1
Clinical effect of Encephabol (pyritinol) in the treatment of cerebrovascular disorders.
J Int Med Res. 1980;8(2):118-26. doi: 10.1177/030006058000800203.
2
Therapeutic effect of pyritinol on sequelae of head injuries.
J Int Med Res. 1981;9(3):215-21. doi: 10.1177/030006058100900312.
3
A placebo-controlled study of pyritinol ('Encephabol') in dementia.
Pharmatherapeutica. 1980;2(5):317-22.
4
Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
Arzneimittelforschung. 1981;31(9):1511-23.
5
[Use of encephabol in the combined therapy of chronic cerebral circulatory failure].
Vrach Delo. 1984 Aug(8):36-8.
6
On the effects of pyritinol on functional deficits of patients with organic mental disorders.
Pharmacopsychiatry. 1986 Sep;19(5):378-85. doi: 10.1055/s-2007-1017274.
7
Use of encephabol in anaesthesia and post-anaesthesia resuscitation.
Anaesthesist. 1979 Nov;28(11):530-2.
8
Contribution to the search for vigilance-indicative EEG variables. Results of a controlled, double-blind study with pyritinol in elderly patients with symptoms of mental dysfunction.
Pharmacopsychiatry. 1986 Mar;19(2):75-83. doi: 10.1055/s-2007-1017159.
9
Pyritinol hydrochloride (encephabol) and senile dementia.
Br Med J. 1979 Apr 28;1(6171):1148. doi: 10.1136/bmj.1.6171.1148.
引用本文的文献
1
Critical review of clinical trials in senile dementia--II.
Postgrad Med J. 1987 May;63(739):337-43. doi: 10.1136/pgmj.63.739.337.
Zotero 插件